Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12

This briefing by Thiru Balasubramaniam of Knowledge Ecology International examines the stalled negotiations within the World Trade Organization (WTO) regarding a waiver of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to improve global access to COVID-19 health technologies ahead of the 12th Ministerial Conference (MC12).

• In October 2020, India and South Africa proposed a TRIPS waiver (IP/C/W/669) to address the COVID-19 pandemic, requesting an exemption from the enforcement and application of Sections 1, 4, 5, and 7 of Part II of the TRIPS Agreement, which cover copyrights, industrial designs, patents, and undisclosed information.
• The European Union opposed the initial waiver proposal, arguing that intellectual property rights were not a significant barrier to accessing COVID-19 technologies. Instead, the EU proposed a counter-proposal in June 2021 focusing on trade facilitation, production expansion, and the clarification of compulsory licensing flexibilities.
• A 'Quadrilateral' group consisting of the United States, India, South Africa, and the European Union held informal negotiations to find a compromise. However, a leaked document and subsequent formal text (IP/C/W/688) showed that the resulting proposal was significantly narrower than the original India-South Africa request, focusing only on vaccines and a single paragraph regarding non-voluntary authorization exports.
• The United States administration insisted that any WTO agreement on COVID-19 vaccines must explicitly exclude China, asserting that China does not require a waiver because it is a major economy with its own vaccine and mRNA technology.
• In March 2020, Costa Rica proposed a 'shared use rights' program for technologies used in the detection, prevention, and treatment of the pandemic, which led to the World Health Organization (WHO) establishing the COVID-19 Technology Access Pool (C-TAP) in May 2020.
• On May 12, 2022, U.S. President Joe Biden announced a licensing agreement involving the U.S. National Institutes of Health, the WHO's C-TAP, and the Medicines Patent Pool, covering 11 technologies including the stabilized spike protein used in current vaccines.

APA

Balasubramaniam, T. (n.d.). Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12. International Institute for Sustainable Development. https://www.iisd.org/es/node/16626

Chicago

Balasubramaniam, Thiru. Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12. International Institute for Sustainable Development, n.d. https://www.iisd.org/es/node/16626.

Wikipedia

{{cite report |last1=Balasubramaniam |first1=Thiru |title=Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12 |publisher=International Institute for Sustainable Development |url=https://www.iisd.org/es/node/16626 |access-date=17 August 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{balasubramaniamndlas, author = {Balasubramaniam, Thiru}, title = {{Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12}}, institution = {International Institute for Sustainable Development}, url = {https://www.iisd.org/es/node/16626}, urldate = {2026-08-17}, note = {Indexed by Climate Insights Directory} }